Palliative local treatment of bone metastases by 125I seed brachytherapy under DynaCT guidance: single-center experience

PURPOSEWe aimed to evaluate the clinical benefit of 125I seed brachytherapy under DynaCT guidance for palliative local treatment of bone metastases.METHODSFrom December 2014 to September 2017, 82 patients with painful bone metastases, who experienced treatment failure using standard strategies or re...

Full description

Bibliographic Details
Main Authors: Yuan Yao, Zhaonan Li, Dechao Jiao, Xueliang Zhou, Jing Li, Xinwei Han
Format: Article
Language:English
Published: Galenos Publishing House 2021-07-01
Series:Diagnostic and Interventional Radiology
Online Access: http://www.dirjournal.org/archives/archive-detail/article-preview/palliative-local-treatment-of-bone-metastases-by-1/54302
_version_ 1827823549965926400
author Yuan Yao
Zhaonan Li
Dechao Jiao
Xueliang Zhou
Jing Li
Xinwei Han
author_facet Yuan Yao
Zhaonan Li
Dechao Jiao
Xueliang Zhou
Jing Li
Xinwei Han
author_sort Yuan Yao
collection DOAJ
description PURPOSEWe aimed to evaluate the clinical benefit of 125I seed brachytherapy under DynaCT guidance for palliative local treatment of bone metastases.METHODSFrom December 2014 to September 2017, 82 patients with painful bone metastases, who experienced treatment failure using standard strategies or rejected treatment were enrolled in this retrospective study. All patients underwent 125I seed brachytherapy under DynaCT guidance. Technical success, visual analogue scale (VAS), numerical rating scale (NRS), verbal rating scale (VRS), Karnofsky performance status (KPS) and complications were analyzed.RESULTSThe success rate of 125I seed implantation was 100%. The VAS and NRS scores for the most severe pain were 7.0 (5.0–9.0) and 8.0 (6.0–9.0) before brachytherapy. The pain scores assessed every 2 hours gradually decreased within 12 hours (p < 0.001). A comparison of KPS scores showed that patients had significantly better quality of life on weeks 1, 4, and 8 than on week 0 (p < 0.001). The associated complications were mild subcutaneous hemorrhage 25.6% (21/82), fever 7.3% (6/82), minor displacement of radioactive seeds 5.0% (4/82), pathologic fracture 2.4% (2/82), and local skin reaction 2.4% (2/82). After symptomatic treatment, all complications were relieved. Minor displacement of radioactive seeds did not cause damage to adjacent tissues. No serious life-threatening complications occurred in the study group.CONCLUSIONDynaCT-guided 125I seed implantation is a safe and effective method for palliation of painful bone metastases from cancer after failure or rejection of conventional treatments.
first_indexed 2024-03-12T02:12:21Z
format Article
id doaj.art-9a91b2767e7a4769bd5137afef0ff143
institution Directory Open Access Journal
issn 1305-3825
1305-3612
language English
last_indexed 2024-03-12T02:12:21Z
publishDate 2021-07-01
publisher Galenos Publishing House
record_format Article
series Diagnostic and Interventional Radiology
spelling doaj.art-9a91b2767e7a4769bd5137afef0ff1432023-09-06T12:19:29ZengGalenos Publishing HouseDiagnostic and Interventional Radiology1305-38251305-36122021-07-0127455856310.5152/dir.2021.2076913049054Palliative local treatment of bone metastases by 125I seed brachytherapy under DynaCT guidance: single-center experienceYuan Yao0Zhaonan Li1Dechao Jiao2Xueliang Zhou3Jing Li4Xinwei Han5 Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China Department of Interventional Radiology, First Affiliated Hospital of Zhengzhou University, Zhengzhou, China PURPOSEWe aimed to evaluate the clinical benefit of 125I seed brachytherapy under DynaCT guidance for palliative local treatment of bone metastases.METHODSFrom December 2014 to September 2017, 82 patients with painful bone metastases, who experienced treatment failure using standard strategies or rejected treatment were enrolled in this retrospective study. All patients underwent 125I seed brachytherapy under DynaCT guidance. Technical success, visual analogue scale (VAS), numerical rating scale (NRS), verbal rating scale (VRS), Karnofsky performance status (KPS) and complications were analyzed.RESULTSThe success rate of 125I seed implantation was 100%. The VAS and NRS scores for the most severe pain were 7.0 (5.0–9.0) and 8.0 (6.0–9.0) before brachytherapy. The pain scores assessed every 2 hours gradually decreased within 12 hours (p < 0.001). A comparison of KPS scores showed that patients had significantly better quality of life on weeks 1, 4, and 8 than on week 0 (p < 0.001). The associated complications were mild subcutaneous hemorrhage 25.6% (21/82), fever 7.3% (6/82), minor displacement of radioactive seeds 5.0% (4/82), pathologic fracture 2.4% (2/82), and local skin reaction 2.4% (2/82). After symptomatic treatment, all complications were relieved. Minor displacement of radioactive seeds did not cause damage to adjacent tissues. No serious life-threatening complications occurred in the study group.CONCLUSIONDynaCT-guided 125I seed implantation is a safe and effective method for palliation of painful bone metastases from cancer after failure or rejection of conventional treatments. http://www.dirjournal.org/archives/archive-detail/article-preview/palliative-local-treatment-of-bone-metastases-by-1/54302
spellingShingle Yuan Yao
Zhaonan Li
Dechao Jiao
Xueliang Zhou
Jing Li
Xinwei Han
Palliative local treatment of bone metastases by 125I seed brachytherapy under DynaCT guidance: single-center experience
Diagnostic and Interventional Radiology
title Palliative local treatment of bone metastases by 125I seed brachytherapy under DynaCT guidance: single-center experience
title_full Palliative local treatment of bone metastases by 125I seed brachytherapy under DynaCT guidance: single-center experience
title_fullStr Palliative local treatment of bone metastases by 125I seed brachytherapy under DynaCT guidance: single-center experience
title_full_unstemmed Palliative local treatment of bone metastases by 125I seed brachytherapy under DynaCT guidance: single-center experience
title_short Palliative local treatment of bone metastases by 125I seed brachytherapy under DynaCT guidance: single-center experience
title_sort palliative local treatment of bone metastases by 125i seed brachytherapy under dynact guidance single center experience
url http://www.dirjournal.org/archives/archive-detail/article-preview/palliative-local-treatment-of-bone-metastases-by-1/54302
work_keys_str_mv AT yuanyao palliativelocaltreatmentofbonemetastasesby125iseedbrachytherapyunderdynactguidancesinglecenterexperience
AT zhaonanli palliativelocaltreatmentofbonemetastasesby125iseedbrachytherapyunderdynactguidancesinglecenterexperience
AT dechaojiao palliativelocaltreatmentofbonemetastasesby125iseedbrachytherapyunderdynactguidancesinglecenterexperience
AT xueliangzhou palliativelocaltreatmentofbonemetastasesby125iseedbrachytherapyunderdynactguidancesinglecenterexperience
AT jingli palliativelocaltreatmentofbonemetastasesby125iseedbrachytherapyunderdynactguidancesinglecenterexperience
AT xinweihan palliativelocaltreatmentofbonemetastasesby125iseedbrachytherapyunderdynactguidancesinglecenterexperience